PR Newswire: news distribution, targeting and monitoring

Epicore BioNetworks Inc. Announces Stock Option Grants

Share with Twitter Share with LinkedIn

CALGARY, Alberta, February 8, 2013 /PRNewswire/ --

Epicore BioNetworks Inc. announces that it has granted stock options to non-executive directors of the company. The number of options granted is 150,000, which is equivalent to 0.6% of Epicore's issued common stock. Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to a maximum of 4,704,246 Epicore common shares. These options have an exercise price of Cdn $0.21 and expire in five years. The grant to directors follows Company board compensation policy.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). [Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.]

For further information:

Mr. William P. Long (Chief Executive Officer)
USA. Tel: +1-609-267-9118
Email: Investors@EpicoreBioNetworks.com

SOURCE Epicore BioNetworks Inc.



Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos and customised feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Get content for your website

Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Start today.

 

 
 

Contact PR Newswire

Send us an email at MarketingUK@prnewswire.co.uk or call us at +44 (0)20 7454 5382

 

 
 

Become a PR Newswire client

Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382

 

 
Regulatory News Search
Search
  
  1. Products & Services
  2. Knowledge Centre
  3. Browse News Releases
  4. Meet the Media
  5. Contact PR Newswire